They also observed statistically significant differences in the expression of IL-9 and IL-22 between the EC, AH, and control groups, with the highest levels of these cytokines noted in the EC group and the lowest in the control group, highlighting their value as diagnostic and prognostic biomarkers in endometrial cancer [55]. This evidence concerns the gene IL9 and endometrial cancer.